| 000 | 02668nam a22005297a 4500 | ||
|---|---|---|---|
| 008 | 161101s20152015 xxu||||| |||| 00| 0 eng d | ||
| 022 | _a0889-8545 | ||
| 040 | _aOvid MEDLINE(R) | ||
| 099 | _a26598306 | ||
| 245 | _aSafety and Efficacy of Contraceptive Methods for Obese and Overweight Women. [Review] | ||
| 251 | _aObstetrics & Gynecology Clinics of North America. 42(4):647-57, 2015 Dec. | ||
| 252 | _aObstet Gynecol Clin North Am. 42(4):647-57, 2015 Dec. | ||
| 253 | _aObstetrics and gynecology clinics of North America | ||
| 260 | _92015 Dec | ||
| 260 | _c2015 | ||
| 260 | _f2016 | ||
| 266 | _d2017-03-06 | ||
| 501 | _aAvailable online from MWHC library: 1996 - present | ||
| 520 | _aIncreasing rates of obesity have become a major public health challenge. Given the added health risks that obese women have during pregnancy, preventing unwanted pregnancy is imperative. Clinicians who provide contraception must understand the efficacy, risks, and the weight changes associated with various contraceptive methods. Despite differences in the pharmacokinetics and pharmacodynamics of hormonal contraceptives in overweight and obese women, efficacy does not appear to be severely impacted. Both estrogen-containing contraceptives and obesity increase the risk of venous thromboembolism, but the absolute risk remains acceptably low in reproductive age women. Copyright (c) 2015 Elsevier Inc. All rights reserved. | ||
| 546 | _aEnglish | ||
| 650 | _a*Contraceptive Agents, Female/ad [Administration & Dosage] | ||
| 650 | _a*Contraceptives, Oral, Hormonal/ad [Administration & Dosage] | ||
| 650 | _a*Family Planning Services | ||
| 650 | _a*Obesity/co [Complications] | ||
| 650 | _a*Venous Thromboembolism/pc [Prevention & Control] | ||
| 650 | _a*Weight Gain/de [Drug Effects] | ||
| 650 | _aAdult | ||
| 650 | _aContraceptive Agents, Female/ae [Adverse Effects] | ||
| 650 | _aContraceptives, Oral, Hormonal/ae [Adverse Effects] | ||
| 650 | _aFemale | ||
| 650 | _aHumans | ||
| 650 | _aObesity/ep [Epidemiology] | ||
| 650 | _aPractice Guidelines as Topic | ||
| 650 | _aRisk Assessment | ||
| 650 | _aUnited States | ||
| 650 | _aVenous Thromboembolism/ci [Chemically Induced] | ||
| 650 | _aVenous Thromboembolism/ep [Epidemiology] | ||
| 650 | _aWomen's Health | ||
| 651 | _aMedStar Washington Hospital Center | ||
| 656 | _aObstetrics and Gynecology/Family Planning | ||
| 657 | _aJournal Article | ||
| 657 | _aReview | ||
| 700 | _aLotke, Pamela S | ||
| 790 | _aKaneshiro B, Lotke PS | ||
| 856 |
_uhttp://dx.doi.org/10.1016/j.ogc.2015.07.005 _zhttp://dx.doi.org/10.1016/j.ogc.2015.07.005 |
||
| 942 |
_cART _dArticle |
||
| 999 |
_c1956 _d1956 |
||